| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | DBV Technologies | 456,893 | 32,492,000 | 31.95% | ||
| 2 | HERON THERAPEUTICS INC | 1,095,734 | 18,879,000 | 18.57% | ||
| 3 | COHERUS BIOSCIENCES INC COM | 305,505 | 8,181,000 | 8.05% | ||
| 4 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 6,200,000 | 6.10% | ||
| 5 | ADVERUM BIOTECHNOLOGIES INC | 1,102,735 | 4,532,000 | 4.46% | ||
| 6 | BIOCRYST PHARMACEUTICALS | 1,005,104 | 4,433,000 | 4.36% | ||
| 7 | LIPOCINE INC NEW | 849,921 | 3,791,000 | 3.73% | ||
| 8 | COLUCID PHARMACEUTICALS INC COM | 68,190 | 2,601,000 | 2.56% | ||
| 9 | AXOVANT SCIENCES LTD | 184,110 | 2,578,000 | 2.54% | ||
| 10 | OCERA THERAPEUTICS INC | 856,550 | 2,261,000 | 2.22% | ||
| 11 | ZAFGEN INC COM | 602,114 | 1,993,000 | 1.96% | ||
| 12 | Ascendis Pharma | 90,000 | 1,809,000 | 1.78% | ||
| 13 | ALCOBRA LTD | 658,910 | 1,628,000 | 1.60% | ||
| 14 | BEIGENE LTD | 51,000 | 1,571,000 | 1.54% | ||
| 15 | STEMLINE THERAPEUTICS INC | 135,420 | 1,467,000 | 1.44% | ||
| 16 | ACHILLION PHARMACEUTICALS INC COM | 180,000 | 1,458,000 | 1.43% | ||
| 17 | EDGE THERAPEUTICS INC | 135,000 | 1,405,000 | 1.38% | ||
| 18 | AKARI THERAPEUTICS PLC | 158,352 | 1,348,000 | 1.33% | ||
| 19 | ARCA biopharma Inc | 462,399 | 1,309,000 | 1.29% | ||
| 20 | CYTOMX THERAPEUTICS INC COM | 64,200 | 1,007,000 | 0.99% | ||
| 21 | REGENXBIO INC COM | 24,089 | 337,000 | 0.33% | ||
| 22 | Audentes Therapeutics, Inc. | 15,000 | 267,000 | 0.26% | ||
| 23 | ProNAi Therapeutics, Inc. | 56,056 | 102,000 | 0.10% | ||
| 24 | AEGLEA BIOTHERAPEUTICS INC COM | 6,000 | 38,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-022473, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
